By Uduak Grace Thomas

This article has been updated from a previous version to correct an error in the total number of genes targeted by Cellecta's Decipher modules.

This week, Ariadne Genomics, Cellecta, and Roswell Park Cancer Institute announced plans to use siRNA screening data to co-develop a knowledgebase of prostate-specific pathway models to support prostate cancer research and drug discovery.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.